• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Dermatologists, Otolaryngologists Differ on Skin Cancer Care

by Thomas R. Collins • November 1, 2013

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

There are certain large tumors where it is clear that Mohs is not appropriate, Dr. Lin said. He said the Mohs approach should be avoided in the setting of “extensive” lesions involving deep structures and in the setting of invasive melanoma, except with lentigo melanoma and in situ melanoma.

You Might Also Like

  • Skin Cancer Care: Meeting Panelists Discuss Approaches
  • SM14: Cases of Aggressive Skin Carcinoma Raise Treatment, Management Questions for Otolaryngologists
  • Advances in Head and Neck Skin Cancer Treatment
  • Advances in Diagnosis, Treatment of Skin Cancer
Explore This Issue
November 2013

Sentinel Lymph Node Biopsy

Cecelia Schmalbach, MD, MS, co-director of the University of Alabama at Birmingham’s Cutaneous Head and Neck Oncology Board, said SLN biopsy is crucial in finding occult disease. It’s a minimally invasive technique to identify the “first echelon” lymph nodes that are mostly likely to harbor occult nodal metastasis.

She emphasized that it is only a staging tool, though, helping to identify who might benefit from adjuvant therapy and to spare patients without nodal disease the morbidity of a formal neck dissection. She noted that more data is needed to determine whether it’s actually therapeutic or could impact survival.

If a patient has a negative SLN biopsy, the current National Comprehensive Cancer Network guidelines say, there’s no need for formal neck dissection, but the patient should be followed clinically. “This is important, because anywhere on the order of 4 to 8 percent of patients will develop a second melanoma and that could be as late as 10 years out from their initial treatment,” she said. SLN for squamous cell carcinoma hasn’t yet been established, but she said that the data so far is “encouraging.”

Carol Bradford, MD, chair of otolaryngology at the University of Michigan, said the issue of whether or not to treat using the Mohs approach is crucial. “We have to consider how we are going to address the neck early enough in all of these patients such that the patients don’t suffer poor outcome due to regional failure,” she added. “Obviously, if patients have had a wide excision by the Mohs surgeon, the opportunity to do any sentinel lymph node biopsy to stage the regional nodal basin is gone.”

Cases of high-risk squamous cell carcinoma patients present a special challenge. “We can watch and wait, but we do know that that’s not a very effective strategy for picking up regional disease early enough to not have it be a big problem,” said Dr. Bradford. “I encourage you to consider strategies at the outset as to how to manage that regional basin.”

As for other malignancy types, serial sectioning and immunostaining are important for detecting small tumor burdens in sentinel nodes.

Pages: 1 2 3 | Single Page

Filed Under: Features, Head and Neck, Practice Focus Tagged With: AAO-HNS annual meeting, Mohs surgery, sentinel lymph node biopsy, skin cancer, treatmentIssue: November 2013

You Might Also Like:

  • Skin Cancer Care: Meeting Panelists Discuss Approaches
  • SM14: Cases of Aggressive Skin Carcinoma Raise Treatment, Management Questions for Otolaryngologists
  • Advances in Head and Neck Skin Cancer Treatment
  • Advances in Diagnosis, Treatment of Skin Cancer

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Would you choose a concierge physician as your PCP?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Keeping Watch for Skin Cancers on the Head and Neck

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Clinical Grading System for Reinke’s Edema

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • Excitement Around Gene Therapy for Hearing Restoration
    • “Small” Acts of Kindness
    • How To: Endoscopic Total Maxillectomy Without Facial Skin Incision
    • Science Communities Must Speak Out When Policies Threaten Health and Safety
    • Observation Most Cost-Effective in Addressing AECRS in Absence of Bacterial Infection

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939